Course opens: 
10/21/2020

Drug Utilization Review (DUR) is a Foundational Component of the Pharmacist’s Standard of Care | August 7, 2025

August 7, 2025

Overview

In this session, we will explore the heightened importance of DUR in the context of pharmacy compounding, outline best practices for conducting thorough reviews, and examine potential drug interactions associated with commonly compounded therapies

Intended audience

    • Pharmacists & Pharmacy Technicians

    Learning Objectives

    Pharmacists and Pharmacy Technicians

    1. Discuss the OBRA 1990 requirement for drug utilization review
    2. Explain the importance of performing a prospective DUR
    3. Recognize some potential interactions with commonly compounded preparations
    4. Identify the steps to perform a DUR and perform interventions

    Hardware/software requirements

    We will be using Zoom for this webinar - full system requirements can be found here. You can download the Zoom client here.

    Web browser

    • Windows: Internet Explorer 11+, Edge 12+, Firefox 27+, Chrome 30+
    • macOS: Safari 7+, Firefox 27+, Chrome 30+
    • Linux: Firefox 27+, Chrome 30+

    Internet connection

    • ~600kbps (down) for high-quality video
    • ~1.2-1.8Mbps (down) for 720p HD video 
    • ~2-3Mbps (down) for 1080p HD video

    Misc

    • Speakers – built-in, USB plug-in, or wireless Bluetooth

    Hardware

     MinimumRecommended
    ProcessorSingle-core 1Ghz or higherDual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent)
    RAMN/A4 GB

     


    COPYRIGHT

    This webinar is Copyright © Alliance for Pharmacy Compounding 2025.

    Course summary
    Available credit: 
    • 0.10 CEU (ACPE)
    • 1.00 Contact Hours
    Event starts: 
    08/07/2025 - 7:00pm
    Event ends: 
    08/07/2025 - 8:00pm
    Price:
    $0.00
    Kathleen Jackson, RPh, PhD (HC), FAPC

    Kathy has over four decades of experience in compounding, beginning with owning and operating her own community pharmacy and later becoming a PCAB Surveyor and independent consultant. She has aided 503(a) and (b) pharmacies with FDA inspections and 483 responses. Kathy is a fellow of IACP (now APC) and a certified sterile compounding trainer. She served two terms on the IACP board, and as the President of the IACP Foundation, as well as chair of the compounding section of the Texas Pharmacy Association. In 2015-2016, she co-authored two IJPC articles on Root Cause Analysis. In 2018, she achieved the CISCI certification from Critical Point for State Board Inspectors. Kathy’s passion lies in helping pharmacies maintain compliance through self-assessment.

    Details coming soon.

    Price

    Price:
    $0.00

    Prerequisites

    Required courses: 
    Please login to Enroll or Add to Waitlist
    Course expires: 
    12/31/2025